These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 6205468

  • 1. HLA antigens of insulin-dependent diabetics. I. PLT colonies detecting Dw10 and a new class II determinant distinct from HLA-D, DR, MB(DC), MT, and SB.
    Sheehy MJ, Quintieri FB, Yang SY, Alosco SM, Matsui Y, Yunis EJ, Gabbay KH.
    Tissue Antigens; 1984 May; 23(5):290-300. PubMed ID: 6205468
    [Abstract] [Full Text] [Related]

  • 2. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G, Giles RC, Ball EJ, Hurley CK, Capra JD, Stastny P.
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [Abstract] [Full Text] [Related]

  • 3. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B, Barolo P, Gadaleta G, Gamba Ansaldi S, Grassi G, Zerbinati A, Molinatti M, Salvetti E.
    Ann Osp Maria Vittoria Torino; 1984 Sep; 27(7-12):185-213. PubMed ID: 6443704
    [Abstract] [Full Text] [Related]

  • 4. A minor subset of HLA-DR3 haplotypes is preferentially increased in type 1 (insulin-dependent) diabetes.
    Sheehy MJ, Rowe JR, Fuller TC, Yunis EJ, Gabbay KH.
    Diabetologia; 1985 Dec; 28(12):891-4. PubMed ID: 3937758
    [Abstract] [Full Text] [Related]

  • 5. Age--related heterogeneity of insulin-dependent diabetes mellitus.
    Deschamps I, Lestradet H, Goderel I, Marcelli-Barge A, Schmid M, Hors J.
    Diabete Metab; 1983 Dec; 9(4):259-63. PubMed ID: 6607851
    [Abstract] [Full Text] [Related]

  • 6. [The HLA system and insulin-dependent diabetes mellitus. A review and personal studies].
    Citro M, Gadaleta G, Gamba Ansaldi S, Molinatti M, Salvetti E, Bruni B.
    Ann Osp Maria Vittoria Torino; 1983 Dec; 26(1-6):108-42. PubMed ID: 6388459
    [Abstract] [Full Text] [Related]

  • 7. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW, Flomenberg N, Horibe K, Winchester R, Radka SF, Dupont B.
    J Immunol; 1986 Oct 15; 137(8):2618-26. PubMed ID: 2428870
    [Abstract] [Full Text] [Related]

  • 8. The characteristics of the HLA antigens determined by cellular techniques.
    Buc M, Stefanovic J.
    Allerg Immunol (Leipz); 1986 Oct 15; 32(1):19-25. PubMed ID: 2424294
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes.
    Matsui Y, Alosco SM, Awdeh Z, Duquesnoy RJ, Page PL, Hartzman RJ, Alper CA, Yunis EJ.
    Immunogenetics; 1984 Oct 15; 20(6):623-31. PubMed ID: 6239824
    [Abstract] [Full Text] [Related]

  • 11. [HLA association of insulin-dependent diabetes mellitus type I (author's transl)].
    Bertrams J, Sodomann P, Gries FA, Sachsse B, Jahnke K.
    Dtsch Med Wochenschr; 1981 Jul 17; 106(29-30):927-32. PubMed ID: 7021118
    [Abstract] [Full Text] [Related]

  • 12. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
    Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, Elbracht R, Schmitz G, Meinl E, Hummel M, Ziegler AG, Wank R, Schendel DJ.
    J Clin Invest; 1997 May 15; 99(10):2405-15. PubMed ID: 9153283
    [Abstract] [Full Text] [Related]

  • 13. Insulin-specific human T cells. Epitope specificity, major histocompatibility complex restriction, and alloreactivity to a diabetes-associated haplotype.
    Miller GG, Pollack MS, Nell LJ, Thomas JW.
    J Immunol; 1987 Dec 01; 139(11):3622-9. PubMed ID: 2445817
    [Abstract] [Full Text] [Related]

  • 14. Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens.
    Biddison WE, Shaw S.
    Diagn Immunol; 1983 Dec 01; 1(3):112-5. PubMed ID: 6209053
    [Abstract] [Full Text] [Related]

  • 15. A new homozygous typing cell with HLA-D"H" (DB6) specificity. Evidence that the DN-1 monoclonal antibody 9w925 is specific for the HLA-D"H" determinant.
    Jakobsen BK, Platz P, Ryder LP, Svejgaard A.
    Tissue Antigens; 1986 May 01; 27(5):285-90. PubMed ID: 2425455
    [Abstract] [Full Text] [Related]

  • 16. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity.
    Bontrop R, Ottenhoff T, Van Miltenburg R, Elferink D, De Vries R, Giphart M.
    Eur J Immunol; 1986 Feb 01; 16(2):133-8. PubMed ID: 3485528
    [Abstract] [Full Text] [Related]

  • 17. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals.
    Naquet P, Ellis J, Tibensky D, Kenshole A, Singh B, Hodges R, Delovitch TL.
    J Immunol; 1988 Apr 15; 140(8):2569-78. PubMed ID: 2451692
    [Abstract] [Full Text] [Related]

  • 18. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.
    Gonwa TA, Picker LJ, Raff HV, Goyert SM, Silver J, Stobo JD.
    J Immunol; 1983 Feb 15; 130(2):706-11. PubMed ID: 6184401
    [Abstract] [Full Text] [Related]

  • 19. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H, Hirata R.
    J Immunol; 1984 Feb 15; 132(2):574-7. PubMed ID: 6418807
    [Abstract] [Full Text] [Related]

  • 20. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL, Mendell N, Kahn CR, Johnson AH, Rosenthal A.
    J Clin Invest; 1983 Sep 15; 72(3):1130-8. PubMed ID: 6411767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.